Last reviewed · How we verify
NCT05148455
Pregnancy-related Changes in Melanocytic Nevi
trial testing standard-of-care clinical skin examination in Melanocytic Nevi (MN) in 50 participants. Completed in 9 February 2022.
2 June 2021
Quick facts
| Lead sponsor | University Hospital, Basel, Switzerland |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 15 January 2021 |
| Primary completion | 2 June 2021 |
| Estimated completion | 9 February 2022 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- standard-of-care clinical skin examination
- skin assessment with the 2D FotoFinder ATBM master system
- data collection by participant questionnaire
Conditions studied
- Melanocytic Nevi (MN) — all drugs for Melanocytic Nevi (MN) →
Sponsor
University Hospital, Basel, Switzerland
Who can join
Adults 18 to 40, female only, with Melanocytic Nevi (MN). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is * to analyze whether more changes in melanocytic nevi (MN) occur in women during and after pregnancy compared to non-pregnant women of the same age * and to analyze psychological effects of total body mapping and dermoscopic examination assisted by artificial intelligence during pregnancy.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
AI-assisted Total Body Dermoscopic Evaluation of Changes in Melanocytic Nevi during Pregnancy: A Prospective, Comparative Study of 2,799 Nevi.
Peter JK, Helfenstein F, Cerminara SE, Maul JT, et al · · 2025 · cited 3× · PMID 39749388 · DOI 10.2340/actadv.v105.41025
Verify or expand the search:
- PubMed search for NCT05148455
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Basel, Switzerland trials
Trials by the same sponsor.
- NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
- NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
- NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
- NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
- NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05148455 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
- Last refreshed: 18 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05148455.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing